Inclisiran (ALN-PCSsc), a double-stranded small interfering RNA (siRNA) compound, serves as the antisense of itself and targets PCSK-9 transcription inhibition. It is employed in the study of hyperlipidemia and cardiovascular disease (CVD) [1].
Molecular Weight:
7699.6
Formula:
C237H291F10N101O134P22S4
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
